Mithila Drugs Private Limited - Company Profile

It is a pharma private limited company based in Udaipur, Rajasthan, India, established in 1995.
1995 Udaipur, Rajasthan, India Active
Last Updated:
Access Report
About Mithila Drugs Private Limited

Mithila Drugs Private Limited, a active private limited company, was established on 13 February 1995 in Udaipur, Rajasthan, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24232RJ1995PTC009496. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹1.20 Cr and a paid-up capital of ₹1.20 Cr.

It upholds a compliant status. Its leadership includes Arvind Jha (Director), Sanjay Kumar Jha (Director), Pramod Kumar Jha (Director). Past directors included Satish Prabhakar Nachane, Ramesh Eknath Jadhav, Sabu Daniel. It holds ₹6.46 Cr open charges and ₹24.35 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Road No. 2, F-70, M.I.A.,, Udaipur, Rajasthan, 313002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232RJ1995PTC009496

  • Registration Number

    009496

  • Incorporation Date

    13 February 1995

  • Authorized Capital

    ₹1.20 Cr

  • Paid-Up Capital

    ₹1.20 Cr

  • ROC Code

    Roc Jaipur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.20 Cr
  • Paid Up Capital ₹ 1.20 Cr
  • Company Age 31 Year, 6 Days
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 6.46 Cr
  • Satisfied Charges ₹ 24.35 Cr
  • Revenue Growth **** -15.66%
  • Profit Growth **** -406.65%
  • Ebitda **** -143.39%
  • Net Worth -17.59%
  • Total Assets -17.89%
Company report

Mithila Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Mithila Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Mithila Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Arvind Jha Director 09 Sep 2008 Current
Sanjay Kumar Jha Director 01 Dec 1996 Current
Pramod Kumar Jha Director 13 Feb 1995 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 20 Sep 2008 Past
Pramod Abcsdd Director 05 Nov 2015 Past
Pramod Abcsdd Director 05 Nov 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Mithila Drugs.

Mithila Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.66% decrease. The company also saw a substantial fall in profitability, with a 406.65% decrease in profit. The company's net worth observed a substantial decline by a decrease of 17.59%.

Mithila Drugs revenue growth over time
Mithila Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -15.66%
*******
*******
*******
*******
Revenue from Operations
*******
 -15.58%
*******
*******
*******
*******
Total Assets
*******
 -17.89%
*******
*******
*******
*******
Profit or Loss
*******
 -406.65%
*******
*******
*******
*******
Net Worth
*******
 -17.59%
*******
*******
*******
*******
EBITDA
*******
 -143.39%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Mithila Drugs?

In 2023, Mithila Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹64,600,000.00

Satisfied Charges

₹243,500,000.00

Charges Breakdown by Lending Institutions
  • Others : 5.72 Cr
  • State Bank Of India : 0.74 Cr
Latest Charge Details
Date Lender Amount Status
06 Jul 2020 State Bank Of India ₹4.70 M Open
06 Jul 2020 State Bank Of India ₹2.70 M Open
29 Dec 2016 Others ₹5.72 Cr Open
20 Jul 2020 Others ₹1.50 M Satisfied
29 Sep 2009 State Bank Of Bikaner And Jaipur ₹1.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Mithila Drugs?

Unlock and access historical data on people associated with Mithila Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mithila Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mithila Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Mithila Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Mithila Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Mithila Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur. was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 5.72 Cr registered on 29 Dec 2016 with Charge ID 100072805 was modified on 29 Mar 2025. was documented.

  • Charges

    The activity A charge registered on 20 Jul 2020 via Charge ID 100377981 with Others was fully satisfied on 13 Oct 2023. was completed.

  • Charges

    A charge with Others amounted to Rs. 0.15 Cr with Charge ID 100377981 was registered on 20 Jul 2020. was recorded as a recent event.

  • Charges

    The activity A charge with State Bank Of India amounted to Rs. 0.47 Cr with Charge ID 100351109 was registered on 06 Jul 2020. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Mithila Drugs Private Limited?

The CIN of Mithila Drugs Private Limited is U24232RJ1995PTC009496.

Where is Mithila Drugs Private Limited headquartered?

Mithila Drugs Private Limited is headquartered at Road No. 2, F-70, M.I.A.,, Udaipur, Rajasthan, 313002.

When was Mithila Drugs Private Limited incorporated?

Mithila Drugs Private Limited was incorporated on 13 February 1995.

Who are the current directors of Mithila Drugs Private Limited?

The current directors of Mithila Drugs Private Limited are

What is the primary industry of Mithila Drugs Private Limited?

The primary industry of Mithila Drugs Private Limited is Manufacturing.

Is Mithila Drugs Private Limited a listed company?

Mithila Drugs Private Limited is unlisted.

What is the capital structure of Mithila Drugs Private Limited?

The authorized capital of Mithila Drugs Private Limited is ₹1.20 Cr, and the paid-up capital is ₹1.20 Cr.

What is the compliance status of Mithila Drugs Private Limited?

The compliance status of Mithila Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available